Papillary thyroid cancer: Surgical management of lymph node metastases

Current Treatment Options in Oncology

Volumn 6, Issue 4, 2005, Pages 311-322

  Caron, Nadine R ^b   Clark, Orlo H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CATECHOLAMINE DERIVATIVE; COLESTYRAMINE; DIGITALIS; ESTROGEN; INSULIN; KETAMINE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; LIOTHYRONINE SODIUM; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANGINA PECTORIS; ASPIRATION BIOPSY; BEAM THERAPY; BERRY PICKING PROCEDURE; BLADDER CANCER; BONE MARROW DISEASE; CERVICAL LYMPH NODE; CONGESTIVE HEART FAILURE; DIAGNOSTIC IMAGING; DIZZINESS; DOSE RESPONSE; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; ECHOGRAPHY; FEVER; FLU LIKE SYNDROME; FLUSHING; FOLLOW UP; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERHIDROSIS; HYPERTHYROIDISM; HYPOGEUSIA; HYPOTHYROIDISM; LACRIMAL DUCT OCCLUSION; LEUKEMIA; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MENSTRUAL IRREGULARITY; NAUSEA; NERVOUSNESS; OLIGOSPERMIA; PATIENT MONITORING; PHYSICIAN ATTITUDE; POSTOPERATIVE COMPLICATION; PRURITUS; RADIATION INJURY; RASH; RECURRENT DISEASE; REVIEW; SECOND CANCER; SENSORY NERVE; SENTINEL LYMPH NODE; SIALOADENITIS; SIDE EFFECT; SMALL INTESTINE CANCER; SURGICAL TECHNIQUE; THYROID PAPILLARY CARCINOMA; URTICARIA; VOMITING; XEROSTOMIA;

EID: 24044498926     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-005-0035-9     Document Type: Review

References (37)

1. Dixon E, McKinnon JG, Pasieka JL: Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000, 24:1396-1401.
2. Kupferman ME, Patterson M, Mandel SJ, et al.: Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130:857-860.
3. Sivanandan R, Soo KC: Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg 2001, 88:1241-1244.
4. Wang TS, Dubner S, Sznyter LA, Heller KS: Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg 2004, 130:110-113.
5. Mann B, Buhr HJ: Lymph node dissection in patients with differentiated thyroid carcinoma: who benefits? Langenbecks Arch Surg 1998, 383:355-358.
6. Caron NR, Clark OH: Well differentiated thyroid cancer. Scand J Surg 2004, 93:261-271.
7. Machens A, Hinze R, Thomusch O, Dralle H: Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002, 26:22-28.
8. Hughes CJ, Shaha AR, Shah JP, Loree TR: Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996, 18:127-132.
9. Yamashita H: Occult microcancer and clinical cancer. Edited by Clark OH, Noguchi, S. St. Louis, Quality Medical Publishing Inc.; 2000, 105-126.
10. Machens A, Holzhausen HJ, Dralle H: Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004, 139:43-45.
11. Ducci M, Appetecchia M, Marzetti M: Neck dissection for surgical treatment of lymph node metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res 1997, 16:333-335.
12. Coatesworth AP, MacLennan K: Cervical metastasis in papillary carcinoma of the thyroid: a histopathologic study. Int J Clin Pract 2002, 56:241-242.
13. Kouvaraki MA, Shapiro SE, Fornage BD, et al.: Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer [discussion]. Surgery 2003, 134:946-954.
14. Moley JF, Wells SA: Compartment-mediated dissection for papillary thyroid cancer. Langenbecks Arch Surg 1999, 384:9-15.
15. Musacchio MJ, Kim AW, Vijungco JD, Prinz RA: Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer. Am Surg 2003, 69:191-196.
16. Bhattacharyya N: Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2003, 129:1101-1104.
17. Shaba AR: Prognostic factors in papillary thyroid carcinoma and implications of large nodal metastasis. Surgery 2004, 135:237-239.
18. Machens A, Hinze R, Lautenschlager C, et al.: Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery 2001, 129:23-28.
19. Clark OH: Predictors of thyroid tumor aggressiveness. West J Med 1996, 165:131-138.
20. Kebebew E, Clark OH: Differentiated thyroid cancer: "complete" rational approach. World J Surg 2000, 24:942-951.
21. Gross ND, Weissman JL, Talbot JM, et al.: Magnetic resonance imaging detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope 2001, 111:1905-1909.
22. Wartofsky L, Sherman SI, Gopal J, et al.: The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998, 83:4195-4203.
23. Wu YJ, Wu HS, Yen RF, et al.: Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography, and Tc-99m tetrofosmin single photon emission computed tomography. Anticancer Res 2003, 23:2973-2976.
24. Dietlein M, Scheidhauer K, Voth E, et al.: Fluorine-18- fluorodeoxyglucose positron emission tomography and iodine - 131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997, 24:1342-1348.
25. Casara D, Rubello D, Saladini G, et al.: Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993, 34:1626-1631.
26. Schlumberger M, Tubiana M, De Vathaire F, et al.: Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986, 63:960-967.
27. Repchinsky C: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Edited by Ottawa, Canada: Canadian Pharmacists Association; 2004, 537:1948-1951.
28. Lin JD, Kao PF, Chao TC: The effects of radioactive iodine in thyroid remnant ablation and treatment of well-differentiated thyroid carcinoma. Br J Radiol 1998, 71:307-313.
29. Ringel MD, Ladenson PW: Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocr Relat Cancer 2004, 11:97-116.
30. Loh KC, Greenspan FS, Gee L, et al.: Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. Clin Endocrinol Metab 1997, 82:3553-3562.
31. Ford D, Giridharan S, McConkey C, et al.: External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 2003, 15:337-341.
32. Cheah WK, Arici C, Ituarte PH, et al.: Complications of neck dissection for thyroid cancer. World J Surg 2002, 26:1013-1016.
33. Kim MK, Mandel SH, Baloch Z, et al.: Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 2004, 130:1214-1216.
34. Henry JF, Gramatica L, Denizot A, et al.: Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998, 383:167-169.
35. Kelemen PF, Van Herle AJ, Giuliano AE: Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998, 133:288-292.
36. Chow TL, Lim BH, Kwok SP: Sentinel lymph node dissection in papillary thyroid carcinoma. ANZ J Surg 2004, 74:10-12.
37. Pasieka JL: Sentinel lymph node biopsy in the management of thyroid disease. Br J Surg 2001, 88:321-322.